GRAIL
Curated by SignalDeveloper of a screening platform for circulating tumor DNA to detect cancer
Overview
Developer of a screening platform for circulating tumor DNA to detect cancer. The company is developing a test called "Galleri" a pan-cancer screening test by measuring circulating nucleic acids in the blood. Its proprietary platform uses the ultra-deep sequencing technique to measure levels of circulating tumor DNA in the patient's blood.
Key facts
- Founded
- 2015
- Headquarters
- Menlo Park, United States
- Stage
- Sign up to view
- Industry
- Life Sciences Technology
Business model
- 3 products and services
- Sign up to view
Contact
- Primary office
- Sign up to view
- Phone
- Sign up to view
Open roles
122 rolesMarketing Operations Specialist #4987
Sunnyvale, CA · On-site · Internship
Senior Corporate Counsel, Compliance (Healthcare) #4927
Sunnyvale, CA · On-site · Internship
Director / Associate Director, International Regulatory Affairs #4809
Sunnyvale, CA · On-site · Internship